World's Best Scientists 2026 revealed!
Robert P. Myers

Robert P. Myers

D-Index & Metrics

Medicine

D-Index
99
Citations
39012
World Ranking
8549
National Ranking
333

Overview

Robert P. Myers is affiliated with the University of Calgary in Canada and has contributed extensively to the field of medicine, particularly focusing on liver-related diseases. Their research spans several subfields including epidemiology, hepatology, surgery, molecular biology, and physiology.

The primary areas of study for their publications include:

  • Liver Disease Diagnosis and Treatment
  • Liver Diseases and Immunity
  • Liver Disease and Transplantation
  • Pancreatitis Pathology and Treatment
  • Hepatitis C virus research
  • Diet, Metabolism, and Disease
  • Pediatric Hepatobiliary Diseases and Treatments

Myers has published a considerable body of work in several academic journals. The most frequent publication venues are:

  • Journal of Hepatology
  • Hepatology
  • Diabetes
  • Clinical Gastroenterology and Hepatology
  • Hepatology Communications

Some of the recent papers authored or co-authored by Myers include the following notable works:

  • "Compassionate Use of Remdesivir for Patients with Severe Covid-19" (2020, New England Journal of Medicine)
  • "Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials" (2020, Journal of Hepatology)
  • "Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial" (2020, Hepatology)
  • "Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH" (2020, Hepatology)
  • "A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH" (2021, Hepatology)

Throughout their career, Myers has collaborated frequently with several co-authors. The individuals most often associated with their work include:

  • Chuhan Chung
  • Zachary Goodman
  • Ryan S. Huss
  • Stephen A. Harrison
  • Arun J. Sanyal

Best Publications

  • Compassionate Use of Remdesivir for Patients with Severe Covid-19.

    Jonathan Grein;Norio Ohmagari;Daniel Shin;George Diaz

  • Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

    Thomas Karlas;David Petroff;Magali Sasso;Jian Gao Fan

  • Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement.

    Richard G. Barr;Giovanna Ferraioli;Mark L. Palmeri;Zachary D. Goodman

  • Migration and Granulomatous Reaction After Periurethral Injection of Polytef (Teflon)

    A.A. Malizia;H.M. Reiman;R.P. Myers;J.R. Sande

  • Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease

    Maitreyi Raman;Iftikhar Ahmed;Patrick M. Gillevet;Chris S. Probert

  • Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

    Gideon M. Hirschfield;Xiangdong Liu;Chun Xu;Yue Lu

  • A Critical Analysis of the Current Knowledge of Surgical Anatomy Related to Optimization of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy

    Jochen Walz;Arthur L. Burnett;Anthony J. Costello;James A. Eastham

  • A comparison of fibrosis progression in chronic liver diseases

    Thierry Poynard;Philippe Mathurin;Ching-Lung Lai;Dominique Guyader

  • Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value

    Puneeta Tandon;Michael Ney;Ivana Irwin;Mang M. Ma

  • Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

    Robert P. Myers;Gilles Pomier-Layrargues;Richard Kirsch;Aaron Pollett

  • Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

    Thierry Poynard;Françoise Imbert-Bismut;Mona Munteanu;Djamila Messous

  • The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

    Rohit Loomba;Eric Lawitz;Parvez S. Mantry;Saumya Jayakumar

  • Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review.

    Abdel Aziz M. Shaheen;Robert P. Myers

  • FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.

    Abdel Aziz M Shaheen;Alex F Wan;Robert P Myers

  • Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

    Robert P Myers;Marie Hélène Tainturier;Vlad Ratziu;Annie Piton

  • Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis

    Xiangdong Liu;Pietro Invernizzi;Yue Lu;Roman Kosoy

  • Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.

    Robert P. Myers;Aaron Pollett;Richard Kirsch;Gilles Pomier-Layrargues

  • Historical epidemiology of hepatitis C virus (HCV) in selected countries

    P. Bruggmann;T. Berg;A. L. H. Øvrehus;C. Moreno

  • Epidemiology of Gallstones

    Laura M. Stinton;Robert P. Myers;Eldon A. Shaffer

  • A Population-Based Study of Pyogenic Liver Abscesses in the United States: Incidence, Mortality, and Temporal Trends

    Liisa Meddings;Robert P Myers;James Hubbard;Abdel Aziz Shaheen

Frequent Co-Authors

Gilaad G. Kaplan
Gilaad G. Kaplan University of Calgary
Thierry Poynard
Thierry Poynard Sorbonne University
Zachary Goodman
Zachary Goodman Inova Fairfax Hospital
Hude Quan
Hude Quan University of Calgary
Zobair M. Younossi
Zobair M. Younossi Inova Health System
Eric Lawitz
Eric Lawitz The University of Texas at Austin
Andrew J. Muir
Andrew J. Muir Duke University
Stephen H. Caldwell
Stephen H. Caldwell University of Virginia
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Mitchell L. Shiffman
Mitchell L. Shiffman Bon Secours Health System

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond traditional medical school, there are several online degree options in the healthcare field that can open rewarding career paths. For those interested in healthcare management and leadership, a health administration degree is a flexible way to start or advance your career in medical facilities and organizations.

If you are considering graduate study, the cost of mha degree programs is an important factor, with many affordable online options available for working professionals. Nurses looking to take on advanced practice or leadership roles can benefit from msn to dnp programs online, which offer doctoral-level education with greater scheduling flexibility.

For those interested in pharmacy, accredited pharmd online programs can prepare you for licensure and clinical roles without needing to relocate. These online programs make it possible to pursue advanced credentials while balancing work and family commitments.

Best Scientists Citing Robert P. Myers

Trending Scientists

Recently Published Articles